- Report
- October 2024
- 192 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 379 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- July 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- August 2024
- 166 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- January 2025
- 185 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- September 2024
- 351 Pages
Global
From €3990EUR$4,197USD£3,352GBP
- Report
- November 2024
- 350 Pages
Global
From €3798EUR$3,995USD£3,191GBP
- Report
- December 2024
- 325 Pages
Global
From €4562EUR$4,799USD£3,833GBP
- Report
- April 2024
- 76 Pages
Global
From €665EUR$700USD£559GBP
€1331EUR$1,400USD£1,118GBP
- Report
- April 2024
- 101 Pages
Global
From €4421EUR$4,650USD£3,714GBP
- Report
- June 2024
- 118 Pages
Global
From €4421EUR$4,650USD£3,714GBP
- Report
- October 2024
- 189 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 183 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 192 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 185 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- December 2024
- 200 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- June 2024
- 120 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- April 2024
- 120 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- February 2025
- 150 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- August 2024
- 147 Pages
Global
From €2851EUR$2,999USD£2,395GBP

The MicroRNA market is a subset of the genomics industry that focuses on the study of small, non-coding RNA molecules. MicroRNAs are involved in a variety of biological processes, including gene expression, development, and disease. They are increasingly being studied as potential therapeutic targets for a variety of diseases, including cancer, cardiovascular disease, and neurological disorders.
The market for microRNA-based therapeutics is growing rapidly, driven by advances in sequencing technology and the development of new delivery systems. Companies are developing a variety of products, including diagnostics, therapeutics, and research tools.
Some of the major players in the microRNA market include Thermo Fisher Scientific, Illumina, Qiagen, Merck, and Novartis. Other companies, such as Exiqon, Bio-Rad, and Bio-Techne, are also active in the market. Show Less Read more